STOCK TITAN

Lantern Pharma (NASDAQ: LTRN) insider holds 570,000 shares, 5.1% stake

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Lantern Pharma Inc. reported that Thomas A. Satterfield, Jr. beneficially owns 570,000 shares of Common Stock, representing 5.1% of the class. The filing breaks the position into 95,000 shares with sole voting/dispositive power and 475,000 shares with shared voting/dispositive power, and cites 11,254,697 shares outstanding as of March 13, 2026.

The filing lists specific holder vehicles: 45,000 shares held by Tomsat Investment & Trading Co., Inc.; 250,000 by Caldwell Mill Opportunity Fund, LLC; 150,000 by A.G. Family L.P.; and 30,000 by Satterfield Vintage Investments, L.P. Ownership links and control relationships are described in the filing.

Positive

  • None.

Negative

  • None.

Insights

Holder disclosed a 5.1% beneficial stake with mixed sole/shared control.

The filing shows a 570,000-share beneficial position with 95,000 shares under sole voting/dispositive power and 475,000 under shared power. The report cites an as of outstanding share count of 11,254,697, which establishes the 5.1% threshold.

Key dependencies are the named entities that hold shares and the control links (e.g., Tomsat Investment & Trading Co., Inc. as a vehicle). Future disclosures may clarify changes if any of those entities trade or reallocate holdings.

Schedule 13G was used to report passive/beneficial ownership structure and related parties.

The statement itemizes holdings across multiple entities and explains relationships (control, general partner roles). It follows Schedule 13G structure by providing voting and dispositive power breakdowns and an outstanding-share anchor date.

Material compliance points: the filing identifies affiliated vehicles and attributes shares accordingly, which helps satisfy beneficial‑ownership disclosure requirements under federal rules.

Beneficially owned 570,000 shares Total beneficial ownership reported in the Schedule 13G
Percent of class 5.1% Percent of common stock based on outstanding shares as of March 13, 2026
Shares outstanding 11,254,697 shares Shares outstanding cited from Form 10-K as of March 13, 2026
Sole voting/dispositive power 95,000 shares Shares with sole voting and dispositive power held by the reporting person
Shared voting/dispositive power 475,000 shares Shares with shared voting and dispositive power held by the reporting person
Tomsat Investment & Trading Co., Inc. 45,000 shares Shares held by the corporate vehicle controlled by Mr. Satterfield
Caldwell Mill Opportunity Fund, LLC 250,000 shares Shares held by the fund managed by an entity in which Mr. Satterfield owns 50%
A.G. Family L.P. 150,000 shares Shares held by a partnership managed by a general partner controlled by Mr. Satterfield
Satterfield Vintage Investments, L.P. 30,000 shares Shares held by the partnership majority-owned by other Satterfield vehicles
Schedule 13G regulatory
"Item 1. (a) Name of issuer: Lantern Pharma Inc."
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficially owned regulatory
"Item 4. Ownership (a) Amount beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared dispositive power regulatory
"6 | Shared Dispositive Power 475,000.00"
sole voting power regulatory
"5 | Sole Voting Power 95,000.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.





51654W101

(CUSIP Number)
03/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: *Based on 11,254,697 shares of common stock of the issuer (the "Common Stock") outstanding as of March 13, 2026, as reported by the issuer in its Annual Report on Form 10-K for the fiscal year ended December 31, 2025.


SCHEDULE 13G



Thomas A. Satterfield, Jr.
Signature:/s/ Thomas A. Satterfield, Jr.
Name/Title:Thomas A. Satterfield, Jr.
Date:04/03/2026

FAQ

How many Lantern Pharma (LTRN) shares does Thomas A. Satterfield, Jr. beneficially own?

He beneficially owns 570,000 shares of common stock. The filing breaks this into 95,000 sole-power shares and 475,000 shared-power shares, representing 5.1% of the class.

What is the basis for the 5.1% ownership figure in the Schedule 13G?

The 5.1% figure is based on 11,254,697 shares outstanding as of March 13, 2026. The filing cites that outstanding-share count from the issuer's Form 10-K for calculation.

Which entities hold shares on behalf of Mr. Satterfield according to the filing?

The filing lists holdings by Tomsat Investment & Trading Co., Inc. (45,000), Caldwell Mill Opportunity Fund, LLC (250,000), A.G. Family L.P. (150,000), and Satterfield Vintage Investments, L.P. (30,000).

How is voting and dispositive power allocated for the reported shares?

The filing reports 95,000 shares where Mr. Satterfield has sole voting and dispositive power, and 475,000 shares where he has shared voting and dispositive power.

Does the Schedule 13G describe control relationships among the holding vehicles?

Yes. It states Mr. Satterfield controls Tomsat Investment & Trading Co., Inc. and identifies management/control relationships for the other entities, including general partner and ownership links.